Researchers sought to determine trends and future patterns for liver, pancreatic, colorectal, stomach, and esophageal cancers in the US.

T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer.

Researchers found that, in the most recent decade evaluated, the incidence of early-onset colorectal cancer increased in 27 countries and territories.

A real-world cohort of patients with metastatic pancreatic adenocarcinoma (mPDAC) demonstrated that prophylaxis therapy to alleviate toxic effects was ...

Researchers investigated the factors associated with treatment delay in patients with early-onset colorectal cancers.

Researchers investigated immune-related adverse effects and characteristics that may predict their incidence in patients receiving ICIs for gastrointestinal cancers.

Increased cancer incidence seen in digestive, endocrine, oral cavity/pharynx, and respiratory systems between 2016 and 2021.

Researchers explored the link between cancer stage at diagnosis and survival outcomes for non-Hispanic Black patients with gastrointestinal cancers.

Nurses, physicians, and other oncology care providers responded to a survey asking for their perspectives on barriers to cancer treatment.

Adjuvant chest wall irradiation should be omitted in most patients meeting the eligibility criteria for SUPREMO,” said Ian Kunkler, MB BChir.

Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD.

Baseline geriatric vulnerabilities and QOL scores are associated with survival after chemotherapy in older adults with metastatic pancreatic cancer, researchers found.